Del realce tardío al T1 mapping.¿Qué queda para nuestra clínica?

  1. Cecconi, Alberto 1
  2. Nogales Romo, Maria Teresa 1
  3. Guzmán Martínez, Gabriela 2
  4. Alfonso, Fernando 1
  5. Jiménez Borreguero, Luis Jesús 1
  1. 1 Departamento de Cardiología. Hospital Universitario de La Princesa. Madrid. España
  2. 2 Departamento de Cardiología. Hospital Universitario La Paz. Madrid. España
Revue:
Revista de Ecocardiografía práctica y otras Técnicas de Imagen Cardíaca (RETIC)

ISSN: 2529-976X

Année de publication: 2019

Titre de la publication: Journal of Practical Echocardiography and Other Cardiac Imaging Techniques

Volumen: 2

Número: 1

Pages: 8-14

Type: Article

DOI: 10.37615/RETIC.V2N1A3 DIALNET GOOGLE SCHOLAR lock_openAccès ouvert editor

D'autres publications dans: Revista de Ecocardiografía práctica y otras Técnicas de Imagen Cardíaca (RETIC)

Résumé

Myocardial fibrosis is a pathological process common to most of heart diseases. However, the type of myocardial involvement can differ significantly depending on its etiology. Tissue characterization of myocardial fibrosis patterns can be explored in a complementary way by the sequences of late gadolinium enhancement and T1 mapping. In this review, we will discuss current evidence for the use of these imaging techniques and describe their most prominent clinical applications.

Références bibliographiques

  • Perea Palazon RJ, Ortiz Perez JT, Prat Gonzalez S, de Caralt Robira TM, Cibeira Lopez MT, Sole Arques M. Parametric techniques for characterizing myocardial tissue by magnetic resonance imaging (part 1): T1 mapping. Radiologia. 2016;58(3):164-77. doi: https://doi.org/10.1016/j.rx.2015.12.007
  • Ambale-Venkatesh B, Lima JA. Cardiac MRI: a central prognostic tool in myocardial fibrosis. Nature reviews Cardiology. 2015;12(1):18-29. doi: https://doi.org/10.1038/nrcardio.2014.159
  • Haaf P, Garg P, Messroghli DR, Broadbent DA, Greenwood JP, Plein S. Cardiac T1 Mapping and Extracellular Volume (ECV) in clinical practice: a comprehensive review. Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance. 2016;18(1):89. doi: https://doi.org/10.1186/s12968-016-0308-4
  • Satoh H, Sano M, Suwa K, Saitoh T, Nobuhara M, Saotome M, et al. Distribution of late gadolinium enhancement in various types of cardiomyopathies: Significance in differential diagnosis, clinical features and prognosis. World journal of cardiology. 2014;6(7):585-601. doi: https://doi.org/10.4330/wjc.v6.i7.585
  • Windecker S, Kolh P, Alfonso F, Collet JP, Cremer J, Falk V, et al. 2014 ESC/EACTS guidelines on myocardial revascularization. EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology. 2015;10(9):1024-94. doi: https://doi.org/10.4244/EIJY14M09_01
  • Romero J, Xue X, Gonzalez W, Garcia MJ. CMR imaging assessing viability in patients with chronic ventricular dysfunction due to coronary artery disease: a meta-analysis of prospective trials. JACC Cardiovascular imaging. 2012;5(5):494-508. doi: https://doi.org/10.1016/j.jcmg.2012.02.009
  • Bekkers SC, Yazdani SK, Virmani R, Waltenberger J. Microvascular obstruction: underlying pathophysiology and clinical diagnosis. Journal of the American College of Cardiology. 2010;55(16):1649-60. doi: https://doi.org/10.1016/j.jacc.2009.12.037
  • Kramer CM. Role of Cardiac MR Imaging in Cardiomyopathies. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 2015;56 Suppl 4:39S-45S. doi: https://doi.org/10.2967/jnumed.114.142729
  • Dass S, Suttie JJ, Piechnik SK, Ferreira VM, Holloway CJ, Banerjee R, et al. Myocardial tissue characterization using magnetic resonance noncontrast t1 mapping in hypertrophic and dilated cardiomyopathy. Circulation Cardiovascular imaging. 2012;5(6):726-33. doi: https://doi.org/10.1161/CIRCIMAGING.112.976738
  • De Cobelli F, Esposito A, Belloni E, Pieroni M, Perseghin G, Chimenti C, et al. Delayed-enhanced cardiac MRI for differentiation of Fabry's disease from symmetric hypertrophic cardiomyopathy. AJR American journal of roentgenology. 2009;192(3):W97-102. doi: https://doi.org/10.2214/AJR.08.1201
  • Schelbert EB, Messroghli DR. State of the Art: Clinical Applications of Cardiac T1 Mapping. Radiology. 2016;278(3):658-76. doi: https://doi.org/10.1148/radiol.2016141802
  • Karamitsos TD, Piechnik SK, Banypersad SM, Fontana M, Ntusi NB, Ferreira VM, et al. Noncontrast T1 mapping for the diagnosis of cardiac amyloidosis. JACC Cardiovascular imaging. 2013;6(4):488-97. doi: https://doi.org/10.1016/j.jcmg.2019.03.026
  • Sado DM, Maestrini V, Piechnik SK, Banypersad SM, White SK, Flett AS, et al. Noncontrast myocardial T1 mapping using cardiovascular magnetic resonance for iron overload. Journal of magnetic resonance imaging : JMRI. 2015;41(6):1505-11. doi: https://doi.org/10.1002/jmri.24727
  • Radunski UK, Lund GK, Stehning C, Schnackenburg B, Bohnen S, Adam G, et al. CMR in patients with severe myocarditis: diagnostic value of quantitative tissue markers including extracellular volume imaging. JACC Cardiovascular imaging. 2014;7(7):667-75. doi: https://doi.org/10.1016/j.jcmg.2014.02.005
  • Tham EB, Haykowsky MJ, Chow K, Spavor M, Kaneko S, Khoo NS, et al. Diffuse myocardial fibrosis by T1-mapping in children with subclinical anthracycline cardiotoxicity: relationship to exercise capacity, cumulative dose and remodeling. Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance. 2013;15:48. doi: https://doi.org/10.1186/1532-429X-15-48
La source de données: Dialnet